InMed sets November 5 record date for merger CVRs
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
InMed Pharmaceuticals has set November 5, 2026, as the record date for contingent value rights tied to its proposed merger with Mentari Therapeutics. Eligible holders receive one CVR per outstanding common share, giving rights to future contingent payments. Distribution depends on shareholder approval of the Return of Capital Proposal at the November 4, 2026 annual and special meeting.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.